Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04407260 · ClinicalTrials.gov registry record
Use of Oxygen Hoods in Patients Failing on Conventional High-flow Oxygen Delivery Systems, Effects on Oxygenation in Hypoxic COVID-19 Patients. Prospective Cohort Study.
A clinical trial, sponsored by Northwell Health.
- Completed
- Registry status
- 136
- Enrollment target
NCT04407260: Completed study, sponsored by Northwell Health.
NCT04407260 is a clinical trial that has completed, run by Northwell Health. The registered enrollment target is 136 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04407260 has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- 136 participants
- Enrollment target
Study Summary
To determine whether the use of oxygen hoods as compared to conventional high-flow oxygen delivery systems, and the effects on oxygenation, mechanical ventilation and mortality rates in hypoxic patients with COVID-19.
Primary Outcome
Continuous pulse oximetry monitoring
Interventions
- DEVICE Oxygen Hood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2020-03-06 |
| Est. Completion | 2020-05-01 |
What the finished NCT04407260 record still lists
NCT04407260 is an observational study that tracks outcomes without assigning an intervention. The registered 136 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Oxygen Hood is the first listed.
NCT04407260 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04407260 about?
NCT04407260 is a clinical study titled "Use of Oxygen Hoods in Patients Failing on Conventional High-flow Oxygen Delivery Systems, Effects on Oxygenation in Hypoxic COVID-19 Patients. Prospective Cohort Study.". To determine whether the use of oxygen hoods as compared to conventional high-flow oxygen delivery systems, and the effects on oxygenation, mechanical ventilation and mortality rates in hypoxic patients with COVID-19.
What is the current status of trial NCT04407260?
This trial is currently completed. The enrollment target is 136 participants. The study started on 2020-03-06. Estimated completion is 2020-05-01.
What interventions are being tested in trial NCT04407260?
The interventions under investigation include: Oxygen Hood (DEVICE).
Who is sponsoring clinical trial NCT04407260?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01555892 · 136 participants · Phase 1
Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE
- NCT03216525 · 136 participants · Phase 3
Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol
- NCT04476901 · 136 participants · Phase 2
Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy
- NCT04603898 · 136 participants · NA
Oxalate Formation From Ascorbic Acid
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI